Metabolic profiles of Fufang Xiling Jiedu capsule in rats by ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry

Author:

Liu Yu‐kang12ORCID,Liu Ce‐jia12,Tian Ru‐fang12,Liu Xin‐cun12,Zhang Yu‐wei12,Zhang Feng‐chao12,Zhang Jing‐hua12,Yao Yuan‐cheng12,Cao Gui‐yun12ORCID,Meng Zhao‐qing12

Affiliation:

1. Shandong Hongjitang Pharmaceutical Group Co., Ltd. Jinan P. R. China

2. Shandong Province Technical Innovation Center of Traditional Chinese Medicine Treatment of Respiratory Diseases Jinan P. R. China

Abstract

Fufang Xiling Jiedu capsule (FXJC), a traditional Chinese medicine that evolved from “Yinqiao Powder”, is widely used for the treatment of cold and influenza. However, due to a lack of in vivo metabolism research, the chemical components responsible for the therapeutic effects still remain unclear. Hence, this study aimed to describe the metabolic profiles of the FXJC in rat plasma, urine, and feces. A combined data mining strategy based on ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry was employed and 201 xenobiotics, including 117 prototype components and 84 metabolites were detected. Phenolic acids, flavonoids, triterpenes, and lignans were prominent ingredients absorbed in vivo, and the major metabolic pathways of the detected metabolites were glucuronidation, sulfation, methylation, and oxidation. This is the first systematic study on the metabolism of the FXJC in vivo, providing valuable information for future studies on the efficacy, toxicity, and mechanism of the FXJC.

Publisher

Wiley

Reference33 articles.

1. Simultaneous determination of fourteen components in Fufang Xiling Jiedu capsules by UPLC‐Q‐TOF‐MS;Cao G;J Pharm Anal,2021

2. Study on quality standard of compound Xiling Jiedu capsules;Sun C;Food Drug,2015

3. Anti‐pandemic influenza A (H1N1) virus potential of Xilingjiedu capsule in vitro;Liu X;Pak J Pharm Sci,2022

4. Health Commission of Shandong Province. Traditional Chinese medicine prevention and treatment plan for SARS‐CoV‐2 in Shandong province (2022 optimized second edition) for China.http://wsjkw.shandong.gov.cn/zwgk/fdzdgknr/tzwj/202212/t20221213_4189390.htmlAccessed: December 13 2022

5. Study on metabolites in vivo of Dangefentong Capsules based on UHPLC‐Q /Orbitrap‐MS /MS;Chen X;Chin J Chin Mater Med,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3